Elevance Raises 2026 Earnings Guidance Despite Potential Medicare Advantage Liability
Elevance raised its 2026 adjusted earnings per share guidance to $26.75 from $25.50, driven by strong first-quarter results. However, a potential $935 million liability related to Medicare Advantage data reporting issues could impact its profits. The guidance for unadjusted earnings was lowered to $19.85 from $22.30.
Topics: Earnings Guidance Financial Liability Healthcare Insurance Medicare Advantage Regulatory Action